1. < Home

NASH

Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD

Truong E, Alnimer L, Gornbein JA, Yang JD, Alkhouri N, Harrison SA, Noureddin M. Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes,[...]

By sjmartinez • March 25, 2025
Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data

Bazargan-Hejazi S, Hines C, Usmani M, Argueta C, Pan D, Brown AF. Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver[...]

By sjmartinez • March 5, 2025
JPEN Journal Club 88. Determining the hypothesis of a study

Koretz RL. JPEN Journal Club 88. Determining the hypothesis of a study. JPEN J Parenter Enteral Nutr. 2024 Oct 10. doi: 10.1002/jpen.2696. Epub ahead of[...]

By sjmartinez • October 11, 2024
Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report. JPGN Rep. 2024 Feb[...]

By sjmartinez • May 17, 2024
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

Liang JX, Ampuero J, Niu H, Imajo K, Noureddin M, Behari J, Lee DH, Ehman RL, Rorsman F, Vessby J, Lacalle JR, Mózes FE, Pavlides[...]

By sjmartinez • August 22, 2023
The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR

Steffen J, Ngo J, Wang SP, Williams K, Kramer HF, Ho G, Rodriguez C, Yekkala K, Amuzie C, Bialecki R, Norquay L, Nawrocki AR, Erion[...]

By sjmartinez • August 5, 2022